Physician profile
Juan Rivera
NPI 1629023965
$8,943.43
in general payments reported to CMS, 2019-2025
29 companies · $1,680 in 2025
The $1,680 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,054 · 2020: $784 · 2021: $929 · 2022: $1,383 · 2023: $1,583 · 2024: $1,530 · 2025: $1,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,793.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,503.57 | 2019-2025 | Tezspire, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $2,297.53 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Mylan Specialty L.P. | $479.76 | 2019-2024 | Yupelri, Yupelri |
| Insmed, INC. | $432.95 | 2019-2025 | Arikayce |
| Regeneron Healthcare Solutions, INC. | $411.41 | 2021-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $404.04 | 2019-2025 | Jascayd, Ofev |
| Genzyme Corporation | $395.44 | 2021-2025 | |
| Baxter Healthcare | $386.38 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Philips North America LLC | $272.00 | 2020-2025 | Respiratory, (O58) Sleep Respiratory Care Und |
| Electromed, INC. | $215.86 | 2023-2025 | Smartvest |
| Janssen Pharmaceuticals, INC | $166.22 | 2020-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $158.30 | 2019-2020 | |
| Pfizer INC. | $138.50 | 2019-2021 | |
| Advanced Respiratory, INC | $100.39 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $95.23 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $81.61 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $68.55 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $52.07 | 2019 | |
| Inogen, INC. | $40.85 | 2023-2025 | Inogen |
| Verona Pharma, INC. | $39.85 | 2025 | Ohtuvayre |
| Shionogi INC | $37.57 | 2022 | |
| Alexion Pharmaceuticals, INC. | $29.66 | 2022 | |
| Genentech USA, INC. | $23.05 | 2020 | |
| Mallinckrodt Hospital Products INC. | $22.93 | 2023 | Acthar |
| Allergan, INC. | $21.50 | 2019 | |
| Grifols USA, LLC | $20.70 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.58 | 2021 | |
| Gilead Sciences, INC. | $16.23 | 2022 | |
| Melinta Therapeutics, LLC | $14.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.